Literature DB >> 1651915

Evidence for hybrid rodent and human insulin receptors in transfected cells.

J E Chin1, J M Tavaré, L Ellis, R A Roth.   

Abstract

Chinese hamster ovary cells and NIH 3T3 cells overexpressing mutant human insulin receptors were examined for the presence of hybrid receptors composed of human and rodent insulin receptors. In the present studies, most of the endogenous rodent receptors were found to be immunoprecipitated from the transfected cells but not the parental cells with a monoclonal antibody specific for human receptor. These data indicate that in these transfected cells, most of the endogenous rodent receptors are in a hybrid complex with the overexpressed human receptor. These results together with the in vitro studies of Treadway et al. (Treadway, J.L., Morrison, B.D., Soos, M.A., Siddle, K., Olefsky, J., Ullrich, A., McClain, D.A., and Pessin, J.E. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 214-218) showing that hybrid receptors exhibit transdominant inhibition explain the prior finding indicating that overexpression of defective insulin receptors interferes with the normal signaling of endogenous receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Tyrosine kinase-deficient mutant human insulin receptors (Met1153-->Ile) overexpressed in transfected rat adipose cells fail to mediate translocation of epitope-tagged GLUT4.

Authors:  M J Quon; M Guerre-Millo; M J Zarnowski; A J Butte; M Em; S W Cushman; S I Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

2.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations.

Authors:  M Dickens; J E Chin; R A Roth; L Ellis; R M Denton; J M Tavaré
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

4.  Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors.

Authors:  S Clark; N Konstantopoulos
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

5.  Human insulin-like growth factor I receptor function in pituitary cells is suppressed by a dominant negative mutant.

Authors:  D Prager; H Yamasaki; M M Weber; S Gebremedhin; S Melmed
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.

Authors:  M P Coghlan; T S Pillay; J M Tavaré; K Siddle
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

7.  Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.

Authors:  T Sasaoka; Y Takata; J Kusari; C M Anderson; W J Langlois; J M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor.

Authors:  R Levy-Toledano; L H Caro; D Accili; S I Taylor
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.